Duloxetine for Major Depression in Peri-/Postmenopausal Women
Status:
Unknown status
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
The main objective of this study is to characterize a range of brain activation symptoms
associated with major depression in peri- and post-menopausal women. Also, assessing brain
activation before and after the treatment might help to uncover some mechanisms associated
with the pathophysiology of depression and menopause.
Phase:
Phase 4
Details
Lead Sponsor:
Hamilton Health Sciences Corporation
Collaborators:
Eli Lilly and Company McMaster University St. Joseph's Healthcare Hamilton